{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260610519993/en/Organon-Secures-US-Food-and-Drug-Administration-Approval-Expanding-Indications-for-TOFIDENCE%C2%AE-tocilizumab-bavi-in-Cytokine-Release-Syndrome-CRS-and-Pediatric-COVID-19", "message": "News view counter 790923 successfully enlarged"}